Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Studies show new role for protein in cancer development

27.06.2003


In two groundbreaking papers published in two prestigious journals over the last two months, University of Southern California researchers have provided evidence of two previously unknown functions for a protein that is central to the transcription of genes. Both papers shed light on the role this protein-called TATA-binding protein, or TBP-may play in promoting the development of cancer.



"What we’ve found is that changes in the cellular concentrations of this critical transcription factor cause specific changes in gene expression patterns, which then contribute to cellular transformation, and a cancer cell phenotype," says Deborah Johnson, Ph.D., professor of molecular pharmacology and toxicology at the USC School of Pharmacy and biochemistry and molecular biology in the Keck School of Medicine.

The first paper, published in Molecular and Cell Biology in May, showed that TBP levels are increased by oncogenic proteins like Ras, one of the first genes found to be involved in human cancers. And that increase, Johnson says, has implications for the development of cancer at the cellular level.


In the cellular production of proteins, the information encoded in DNA is transcribed different types of RNA-ribonucleic acid. This process occurs with the help of enzymes called RNA polymerases. There are three RNA polymerases found in a typical cell, and TATA-binding protein has been shown-by Johnson’s lab and others-to be absolutely critical to the function of all of them.

Because TBP is so central and so basic to the process of transcription, Johnson explains, it was long assumed that its cellular levels remain steady at all times. "It was viewed as a housekeeping protein. Nobody even thought that it could be regulated," she said.

When Johnson questioned that assumption and tried manipulating TBP levels in cells, she found that they could indeed be upregulated-and that the proteins that were especially good at increasing TBP levels were proteins like Ras, which are associated with cancer.

Knowing that oncogenic proteins can raise TBP levels in a laboratory dish was one thing; finding out what happens in a living cell when TBP levels rise was another. "That was the next question we asked," Johnson says. "We wanted to know whether TBP was actually driving Ras to transform normal cells into malignant cells."

In a series of experiments and collaborations with a number of researchers from the Keck School of Medicine, Johnson was able to show that when cells are manipulated so that TBP levels can no longer be increased, Ras is no longer able to transform cells.

And when she increased TBP levels without Ras being present, she found that oncogenesis continued unabated. "In fact," notes Johnson, "we tested it in an animal model, and found that increased TBP alone, without Ras, still leads to tumors in nude mice."

Whether TBP plays a similar role in the development of cancer in humans is something that Johnson is now pursuing in collaboration with USC/Norris Cancer Center pathologist Louis Dubeau, M.D., Ph.D., testing tumor cells for their TBP levels. "If TBP is a true contributor to oncogenesis," Johnson says, "we should see increased TBP levels in a clinically relevant proportion of patients." Preliminary data gathered thus far support this hypothesis.

The second study, published in the June issue of The EMBO Journal (EMBO is the European Molecular Biology Organization), looked at the other side of the oncogenesis coin. "We found in the Molecular and Cellular Biology paper that oncogenes like Ras can increase cellular concentrations of TBP," notes Johnson. "If that’s true, then we might expect tumor suppressors to reduce the level of TBP."

To find out if their expectations were correct, Johnson and her colleagues looked at p53, a tumor suppressor that’s found to be mutated in about half of all human cancers. "P53 keeps cells from growing and proliferating out of control," Johnson says.

Like TBP, p53 is also a transcription factor, regulating expression of the genes involved in cell cycle control and apoptosis, the cellular version of suicide. And previous studies have shown that p53 can bind to TBP. But what the biological relevance of that was had gone unreported, until now.

To determine the relevance, Johnson manipulated the levels of p53 in cells, watching to see what happened with TBP in those cells. What she found was that p53 seems to suppress an important function of TBP, preventing it from working with one of the RNA polymerases. "It’s not changing the cellular concentration of TBP," Johnson explains, "but is instead changing its effective concentration, preventing TBP from forming a complex with other proteins. Forming that complex is essential to TBP’s role in transcribing genes."

These two studies, Johnson points out, are really just complementary parts of a larger picture of the role of TBP in oncogenesis. "With these papers," she says, "we now have two very different scenarios that show that increasing the TBP concentration in a cell leads to that cell’s ability to transform into a tumor cell. And in the second scenario, we have a tumor suppressor that decreases the effective concentration of TBP by altering its ability to function. Together, they both contribute to the ability of the cell to transform from normal to malignant."



Sandra A. S. Johnson, Louis Dubeau, Michael Kawalek, Andrew Dervan, Axel H. Schonthal, Chi V. Dang, Deborah Johnson, "Increased Expression of TATA-Binding Protein, the Central Transcription Factor, Can Contribute to Oncogenesis." Molecular and Cellular Biology, May 2003.

Diane Crighton, Annette Woiwode, Cheng Zhang, Nihar Mandavia, Jennifer P. Morton, Lorna J. Warnock, Jo Milner, Robert J. White, Deborah L. Johnson, "p53 Represses RNA Polymerase III Transcription by Targeting TBP and Inhibiting Promoter Occupancy by TFIIB." The EMBO Journal, June 2, 2003.

Jon Weiner | EurekAlert!
Further information:
http://www.usc.edu/

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>